MENQUADFI SOLUTION FOR INJECTION
Product details
Registration number: SIN16454P
Classification: Prescription Only
Active ingredients:
- Meningococcal Polysaccharide, Serogroup A (Monovalent Conjugate)
- Meningococcal Polysaccharide, Serogroup C (Monovalent Conjugate)
- Meningococcal Polysaccharide, Serogroup W-135 (Monovalent Conjugate)
- Meningococcal Polysaccharide, Serogroup Y (Monovalent Conjugate)
- Tetanus Toxoid, Filtered Concentrate (Carrier Protein)
Strength:
- 10 mcg/ 0.5 mL
- 10 mcg/ 0.5 mL
- 10 mcg / 0.5mL
- 10 mcg/ 0.5 mL
- 55 mcg/ 0.5 mL
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
ATC code: J07AH08
HSA approval date: 29 March 2022
Manufacturer(s): Sanofi Pasteur, Inc.
Manufacturing country/countries: UNITED STATES
What are the HSA registration number and classification for MENQUADFI SOLUTION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16454P
Classification: Prescription Only
What active ingredients and strength are recorded for MENQUADFI SOLUTION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Meningococcal Polysaccharide, Serogroup A (Monovalent Conjugate)
- Meningococcal Polysaccharide, Serogroup C (Monovalent Conjugate)
- Meningococcal Polysaccharide, Serogroup W-135 (Monovalent Conjugate)
- Meningococcal Polysaccharide, Serogroup Y (Monovalent Conjugate)
- Tetanus Toxoid, Filtered Concentrate (Carrier Protein)
Strength:
- 10 mcg/ 0.5 mL
- 10 mcg/ 0.5 mL
- 10 mcg / 0.5mL
- 10 mcg/ 0.5 mL
- 55 mcg/ 0.5 mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MENQUADFI SOLUTION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR
Who is the recorded registrant for MENQUADFI SOLUTION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for MENQUADFI SOLUTION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Sanofi Pasteur, Inc.
Manufacturing country/countries: UNITED STATES
Where can I look up MENQUADFI SOLUTION FOR INJECTION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16454P or the exact product name MENQUADFI SOLUTION FOR INJECTION. The general register link does not preselect this product.
What are the source dates for this MENQUADFI SOLUTION FOR INJECTION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MENQUADFI SOLUTION FOR INJECTION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16454P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)